Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyltransferase is a general term for a class of enzymes that catalyze the transfer of acyl groups from acyl donors (commonly acyl-CoA) to acceptor molecules, such as alcohols, amines, or other biomolecules. This group encompasses diverse families essential for lipid biosynthesis (e.g., triglycerides, phospholipids, cholesterol esters), protein acylation, and the regulation of many metabolic and signaling pathways. Specific members include Glycerol-3-phosphate acyltransferases, acyl-CoA:cholesterol acyltransferases (ACAT/SOAT), and toxin-activating acyltransferases among others. Each individual acyltransferase has unique substrate specificities, tissue distributions, and disease implications.
Inhibition of substrate acylation (for ACAT inhibitors); Disruption of lipid biosynthesis (for specific family members, e.g., GPAT/AGPAT inhibitors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyltransferase.